{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-25-000012","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.629635+00:00","generated_at":"2026-05-21T15:34:57.536188+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NeuroPace reports record Q1 revenue $22.5M (+24% YoY), raises FY2025 guidance to $93-97M","bullets":["Record quarterly revenue $22.5M, up 24% YoY; RNS System revenue up 29% excluding NAUTILUS study implants.","Gross margin 77.0% exceeded full-year guidance of 73-75%; operating loss narrowed to $5.1M from $7.5M.","Full-year 2025 revenue guidance raised to $93-97M (16-21% growth); expects NAUTILUS topline data in H2 2025.","Strategic refocus on core RNS System; terminating SEEG distribution relationship starting Q4 2025 through Q1 2026.","Cash and investments $66.3M; long-term debt $59.8M as of March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-25-000012","json":"https://secwatch.observer/filing/0001528287-25-000012.json","markdown":"https://secwatch.observer/filing/0001528287-25-000012.md","text":"https://secwatch.observer/filing/0001528287-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/0001528287-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/npce-20250513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T15:34:57.536188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}